InvestorsHub Logo
Followers 1183
Posts 134793
Boards Moderated 3
Alias Born 08/27/2003

Re: ronin86 post# 92158

Thursday, 06/19/2014 12:13:45 AM

Thursday, June 19, 2014 12:13:45 AM

Post# of 146240
ronin: FDA did NOT grant priority voucher. Orphan drug status is VERY different. Priority vouchers are only given AFTER the company has successfully brought ANOTHER drug to market. The FDA gives the priority review as a "thank you" to the company for addressing an orphan disease with their other first drug.

First you bring an orphan disease treatment to market and THEN you are given a priority review voucher.

NNVC has done neither.

And if one prefers scheme vs. scam, that's ok. Either way, we all know what fraud is, generally speaking.

The SwingTrade Portfolio is up 28.3% YTD, 83.5% in 2013, and 475.5% since inception.
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=102716798

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NNVC News